Logo image of HCM

HUTCHMED CHINA-ADR (HCM) Stock Overview

USA - NASDAQ:HCM - US44842L1035 - ADR

15.98 USD
-0.23 (-1.42%)
Last: 10/7/2025, 8:00:01 PM

HCM Key Statistics, Chart & Performance

Key Statistics
52 Week High21.5
52 Week Low11.51
Market Cap2.75B
Shares171.87M
Float99.27M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.72
PE5.88
Fwd PE33.68
Earnings (Next)03-17 2026-03-17/amc
IPO05-19 2006-05-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


HCM short term performance overview.The bars show the price performance of HCM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

HCM long term performance overview.The bars show the price performance of HCM in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of HCM is 15.98 USD. In the past month the price decreased by -0.44%. In the past year, price decreased by -18.01%.

HUTCHMED CHINA-ADR / HCM Daily stock chart

HCM Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52.24 798.46B
JNJ JOHNSON & JOHNSON 18.89 454.91B
AZN ASTRAZENECA PLC-SPONS ADR 19.34 266.24B
NVO NOVO-NORDISK A/S-SPONS ADR 15.09 262.25B
NVS NOVARTIS AG-SPONSORED ADR 14.86 254.66B
MRK MERCK & CO. INC. 11.38 218.83B
PFE PFIZER INC 7.75 149.36B
SNY SANOFI-ADR 11.08 119.89B
BMY BRISTOL-MYERS SQUIBB CO 6.64 90.90B
GSK GSK PLC-SPON ADR 9.65 87.55B
ZTS ZOETIS INC 22.95 63.27B
TAK TAKEDA PHARMACEUTIC-SP ADR 49.86 45.67B

About HCM

Company Profile

HCM logo image HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,780 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Company Info

HUTCHMED CHINA-ADR

48th Floor, Cheung Kong Center, 2 Queen's Road Central

Hong Kong HK

CEO: Christian Hogg

Employees: 1780

HCM Company Website

HCM Investor Relations

Phone: 85221281188

HUTCHMED CHINA-ADR / HCM FAQ

What is the stock price of HUTCHMED CHINA-ADR today?

The current stock price of HCM is 15.98 USD. The price decreased by -1.42% in the last trading session.


What is the ticker symbol for HUTCHMED CHINA-ADR stock?

The exchange symbol of HUTCHMED CHINA-ADR is HCM and it is listed on the Nasdaq exchange.


On which exchange is HCM stock listed?

HCM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for HUTCHMED CHINA-ADR stock?

27 analysts have analysed HCM and the average price target is 17.05 USD. This implies a price increase of 6.67% is expected in the next year compared to the current price of 15.98. Check the HUTCHMED CHINA-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is HUTCHMED CHINA-ADR worth?

HUTCHMED CHINA-ADR (HCM) has a market capitalization of 2.75B USD. This makes HCM a Mid Cap stock.


How many employees does HUTCHMED CHINA-ADR have?

HUTCHMED CHINA-ADR (HCM) currently has 1780 employees.


What are the support and resistance levels for HUTCHMED CHINA-ADR (HCM) stock?

HUTCHMED CHINA-ADR (HCM) has a support level at 15.91 and a resistance level at 16.14. Check the full technical report for a detailed analysis of HCM support and resistance levels.


Is HUTCHMED CHINA-ADR (HCM) expected to grow?

The Revenue of HUTCHMED CHINA-ADR (HCM) is expected to decline by -11.78% in the next year. Check the estimates tab for more information on the HCM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HUTCHMED CHINA-ADR (HCM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HUTCHMED CHINA-ADR (HCM) stock pay dividends?

HCM does not pay a dividend.


When does HUTCHMED CHINA-ADR (HCM) report earnings?

HUTCHMED CHINA-ADR (HCM) will report earnings on 2026-03-17, after the market close.


What is the Price/Earnings (PE) ratio of HUTCHMED CHINA-ADR (HCM)?

The PE ratio for HUTCHMED CHINA-ADR (HCM) is 5.88. This is based on the reported non-GAAP earnings per share of 2.72 and the current share price of 15.98 USD. Check the full fundamental report for a full analysis of the valuation metrics for HCM.


What is the Short Interest ratio of HUTCHMED CHINA-ADR (HCM) stock?

The outstanding short interest for HUTCHMED CHINA-ADR (HCM) is 0.42% of its float. Check the ownership tab for more information on the HCM short interest.


HCM Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to HCM. When comparing the yearly performance of all stocks, HCM is a bad performer in the overall market: 80.43% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

HCM Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to HCM. HCM has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HCM Financial Highlights

Over the last trailing twelve months HCM reported a non-GAAP Earnings per Share(EPS) of 2.72. The EPS increased by 1172.34% compared to the year before.


Industry RankSector Rank
PM (TTM) 77.53%
ROA 26.29%
ROE 37.99%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%1661.49%
Sales Q2Q%-9.16%
EPS 1Y (TTM)1172.34%
Revenue 1Y (TTM)-1.41%

HCM Forecast & Estimates

27 analysts have analysed HCM and the average price target is 17.05 USD. This implies a price increase of 6.67% is expected in the next year compared to the current price of 15.98.

For the next year, analysts expect an EPS growth of 897.09% and a revenue growth -11.78% for HCM


Analysts
Analysts83.7
Price Target17.05 (6.7%)
EPS Next Y897.09%
Revenue Next Year-11.78%

HCM Ownership

Ownership
Inst Owners21.97%
Ins Owners0.58%
Short Float %0.42%
Short Ratio8.28